Dan Cohen, MD | Psychiatrist.com

Original Research

Dried Blood Spot Analysis for Drug Monitoring of Clozapine

October 24, 2017

Therapeutic drug monitoring during clozapine therapy can be inconvenient as well as uncomfortable for patients. This study tested a novel method of dried blood spot (finger prick) monitoring as...

Lisanne M. Geers, Dan Cohen, Laura M. Wehkamp, et al

Original Research

Advanced Glycation End Products in Early Psychosis

April 25, 2017

While cardiovascular disease management has progressed significantly in the general population, the same is not true for patients with severe mental illness. Read this study to explore ways to...

Julia M. Hagen, Arjen L. Sutterland, Maarten W. Koeter, et al

Meta-Analysis

Topiramate-Antipsychotic Cotreatment

June 22, 2016

Topiramate is known to cause weight loss, but it's also known to cause adverse psychiatric side effects. So how would topiramate affect patients already taking antipsychotics? Read this meta-analysis...

Christoph U. Correll, Lawrence Maayan, John Kane, et al

Review Article

Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy

October 15, 2012

Dan Cohen, Jan P. A. M. Bogers, Daniel van Dijk, et al

ASCP Corner

Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

May 13, 2009

Dan Cohen, Christoph U. Correll

Letter to the Editor

Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia

August 15, 2007

Dan Cohen

Letter to the Editor

Reply to "Antipsychotic Medication and Diabetes."

March 15, 2005

Dan Cohen, Ronald P. Stolk

Letter to the Editor

Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan

February 15, 2005

Dan Cohen

Original Research

Antipsychotic Drugs May Worsen Metabolic Control in Type 2 Diabetes Mellitus

May 1, 2004

José A. Spoelstra, Ronald P. Stolk, Dan Cohen, et al